Transcend Capital Advisors, LLC Viatris Inc Transaction History

Transcend Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$10.05 - $12.02 $2,432 - $2,908	-242 Reduced 2.34%	10,104 $107,000
Q1 2024 May 03, 2024	SELL	$11.27 - $13.53 $7,269 - $8,726	-645 Reduced 5.87%	10,346 $123,000
Q4 2023 Feb 05, 2024	SELL	$8.77 - $10.85 $149 - $184	-17 Reduced 0.15%	10,991 $119,000
Q3 2023 Oct 31, 2023	BUY	$9.59 - $11.35 $105,566 - $124,940	11,008 New	11,008 $108,000
Q3 2022 Oct 17, 2022	BUY	$8.48 - $11.13 $356 - $467	42 Added 0.41%	10,209 $87,000
Q2 2022 Jul 12, 2022	SELL	$9.95 - $12.27 $587 - $723	-59 Reduced 0.58%	10,167 $106,000
Q1 2022 Apr 20, 2022	BUY	$9.81 - $15.4 $100,317 - $157,480	10,226 New	10,226 $111,000

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Transcend Capital Advisors, LLC with notifications on news.